BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,826 | -62.0% | 44,200 | 0.0% | 0.00% | – |
| Q2 2023 | $294,372 | -62.7% | 44,200 | +4.5% | 0.00% | -100.0% |
| Q1 2023 | $789,318 | -20.6% | 42,300 | -8.6% | 0.00% | 0.0% |
| Q4 2022 | $994,524 | +81.8% | 46,300 | 0.0% | 0.00% | – |
| Q3 2022 | $547,000 | -10.5% | 46,300 | 0.0% | 0.00% | – |
| Q2 2022 | $611,000 | -36.9% | 46,300 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $968,000 | +12.3% | 46,300 | +9.2% | 0.00% | 0.0% |
| Q4 2021 | $862,000 | -33.0% | 42,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,287,000 | +4.5% | 42,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,232,000 | -14.6% | 42,400 | +26.9% | 0.00% | 0.0% |
| Q1 2021 | $1,442,000 | +3.0% | 33,400 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $1,400,000 | -3.9% | 30,300 | -9.8% | 0.00% | 0.0% |
| Q3 2020 | $1,457,000 | +21.6% | 33,600 | +48.7% | 0.00% | 0.0% |
| Q2 2020 | $1,198,000 | – | 22,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 15,040 | $177,772,000 | 0.69% |
| AlphaCentric Advisors LLC | 50,000 | $591,000 | 0.61% |
| Artemis Investment Management LLP | 1,374,496 | $16,260,000 | 0.18% |
| Knoll Capital Management, LLC | 20,000 | $236,000 | 0.14% |
| Game Plan Financial Advisors, LLC | 11,280 | $133,000 | 0.11% |
| Virtus ETF Advisers LLC | 11,365 | $134,000 | 0.05% |
| AllSquare Wealth Management LLC | 5,527 | $65,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 34,231 | $405,000 | 0.03% |
| Aquatic Capital Management LLC | 10,000 | $118,000 | 0.01% |
| Jump Financial, LLC | 26,000 | $307,000 | 0.01% |